Progesterone downregulates the expression of DSCAM-AS1 specifically in PR-positive breast cancer cells, wherein PR modulates the genomic binding pattern of ER, the classical activator of DSCAM-AS1 [27], in response to progesterone. This evidence concerns the gene ESR1 and breast cancer.